$2.34
-0.04-1.68%
Pre-Market: 8:49 AM EDT
15 minutes delayed
Protara Therapeutics
TARANASDAQ
Protara Therapeutics (TARA) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestProtara Therapeutics (NASDAQ:TARA) Stock Quotes, Forecast and News Summary
Protara Therapeutics Stock (NASDAQ: TARA) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 298.79K |
| Day Range | - - - |
| 52 Wk Range | 1.04 - 5.24 |
| Market Cap | $48.18M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 51 |
| Short Interest | 11.43% |
| Days to Cover | 7.17 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Protara Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for peop...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Protara Therapeutics (TARA) stock?
You can purchase shares of Protara Therapeutics (NASDAQ:TARA) through any online brokerage.
Who are Protara Therapeutics (TARA) competitors?
Other companies in Protara Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX), CARISMA Therapeutics (NASDAQ:CARM) and Curis (NASDAQ:CRIS).
What is the target price for Protara Therapeutics (TARA) stock?
There is no analysis for Protara Therapeutics.
What is the forecast for Protara Therapeutics (TARA) stock?
Protara Therapeutics has a consensus price target of $25.00.
Current stock price for Protara Therapeutics (TARA)?
The stock price for Protara Therapeutics (NASDAQ: TARA) is $2.38 last updated July 15, 2024 at 4:00 PM EDT.
Does Protara Therapeutics (TARA) pay a dividend?
There are no upcoming dividends for Protara Therapeutics.
When is Protara Therapeutics (NASDAQ:TARA) reporting earnings?
Protara Therapeutics’s Q2 earnings are confirmed for Thursday, August 1, 2024.
Is Protara Therapeutics (TARA) going to split?
There is no upcoming split for Protara Therapeutics.
What sector and industry does Protara Therapeutics (TARA) operate in?
Protara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.